(Q50928065)
Statements
Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong. (English)
1 reference
Pak-Leung Ho
1 reference
Kin-Hung Chow
1 reference
Herman Tse
1 reference
Vincent C C Cheng
1 reference
12 July 2012
1 reference
40
1 reference
3
1 reference
280-281
1 reference